Member Info for Badsterman

Good stuff Tommy,

We've also got the Hokkaido Uni evaluation result due in December.

Cathy has links to Japan and has likely seen something she really likes in Valirx.

Where's Porky Boy and his 6p raise?

Negativity and desperation abound in this thread, can I join in?

Simon's floundering out of his depth, burning cash and filling his pockets whilst failing to deliver anything.

He's following the same doomed pattern as his "Test and Trace" and Morrisons debacles.

The dividend party has now finished and Simon's Xmas plan will be an unmitigated disaster, again

A situation best described as catastrophic.

Lollydolly, what wisdom!!

Your statement..."needs to give us an indication of timescales"

Complete and utter rubbish, yet again.

Cliff had said many times his target is either IPO, or sale, in the near future.

I'm happy to rely on Cliff's judgement on timing, over that of a needy lollywally who wants rough dates in their diary.

You're yet another "instant gratification" investor that seem to infest chat boards these days.

Just be patient!!

Lordloadsofwaffle wants his reward and says...."but we now need to know when"..

What an utterly absurd statement.

If investors and companies knew exactly when things will happen we'd all have "loadsoflolly".

I can't wait for your next pearl of wisdom.

Very fair options,

A sensible tariff of vesting criteria to promote company performance.

Back to waiting (again)..

GLA.

Tulsatel,

It's a little harsh to complain of operating cost losses for a start-up. What exactly were you expecting?

At least wait until Lucy produce a trading update.

You say the "business model is unfolding", yet LUCY has barely been listed for two weeks.

You're typical of the type of "instant gratification" investor that populates so many chat boards these days.

I follow Lucyd on Facebook and today they changed their profile name to: Lucyd Glasses

Likely so the name better reflects the product and improves sales.

The first trading update will be crucial.

Yes please,

Wouldn't that be something - £2.36!!

As I write SAR is up nearly 10%, and VAL almost 9%.

Something has got to be brewing in one of my biotech plays!!

GLA.

Pin,

Born and bred, sir.

They wouldn't let me in a golf club, until I took elocution lessons (!)

Jokes and accents aside, its a beautiful area to live in.

Regards.

Morning,

It's very stormy in Norfolk,

A couple of thoughts;

1. Staying positive.
I'm trying to switch my mindset away from legacy asset delays towards the future of Valirx. I hope more reseach and information about the evaluations will soon be forthcoming.

2. Rhubarb vs DYOR
He's such a likeable, knowledgable chap, and posts so eloquently, that it's almost impossible not to consider his opinion.

That said, I got burned in SNG despite so called experts, like Sir Stephen Holgate.

Maybe I should switch off the 'puter and take the Heinz 57 out for a wander.

After all, its only money!!

GLA.

Barnetpeter states, "this first IPO", in a thread about the LUCY share price.

I don't value the "researched" opinion of someone who completely missed the Belluscura IPO.

Valirx's future is filled with potential.

The fact we MAY get TNBC "in vivo" data, at this early stage, is truly exciting.

We might see further peptides, the use of more cutting edge science and additional evaluations.

I imagine Suzy has got so bored answering legacy asset questions she's decided to employ a marketing company!

It's made me appreciate the huge amount of other clinical development work that's been going on.

Sorry Suzy - I hereby promise not to whinge about the TRX deal anymore!!

Now, back to waiting....

GLA.

Valirx's future is filled with potential.

The fact we MAY get TNBC "in vivo" data, at this early stage, is truly exciting.

We might see further peptides, the use of more cutting edge science and additional evaluations.

I imagine Suzy has got so bored answering legacy asset questions she's decided to employ a marketing company!

It's made me appreciate the huge amount of other clinical development work that's been going on.

Sorry Suzy - I hereby promise not to whinge about the TRX deal anymore!!

Now, back to waiting....

GLA.

Thank you for the reply,

A very detailed and thought provoking read.

We just need one piece of good news from the pipeline (legacy drug or new evaluation), to propel Suzy's vision forward.

It's gotta be close......it's the waiting!!

GLA

Rhub,

The three evaluation RNS's use bold statements such as, "novel mechanism of action", "cutting edge tech" and "treatment of previously undruggable KRAS".

The King's College website (re: TNBC) says "Therapeutic peptides are a relatively new treatment for cancer". This suggests we may have commercial competition in these areas of research?

Would I be right in thinking, once patented, Valirx would have first mover advantage in the technology, such that we could develop peptidomimetics for other indications?

Thanks.

PS; I'm not a scientist!!

Its too late,

Thompson's tweets failed dismally to resonate with the public, so he's busy updating his CV with yet another fiscal disaster.

Meanwhile, the share price continues its downward trajectory and the 2023/4/5 dividend prospects have vanished.

Williams is fiddling nervously whilst awaiting the sight of the GLS cash cow on the horizon, to save him from the impending apocalypse.

https://www.indy100.com/news/royal-mail-strike-cwu-union

GLA.

A series of tweets aimed at the CWU, replied to with howls of derision from the Great British Public.

I thought marketing and communication was part of Simon's "skillset"?

https://twitter.com/royalmailnews/status/1560195307757096962?t=QFJSQX84piPeFkPOQTRg6w&s=19

Bye Simon.

Aww JB, sounds like you're giving me the brush off?

If Thompson was such a roaring success at Morrisons, why did they get rid of him?

He left Apple, after less than two years, for an NHS job?

Then your reply to Angers states;

"he (Thompson) could have been more prudent" and "anticipated issues".

I wholeheartedly agree and suggest that's because his failings are demonstrated by a track record of fiscal indiscipline and poor planning.

I do hope your paltry 2023 RMG dividend buys you a beer or two.

Best regards

JB,

Specifically, Morrisons.

Under performing Thompson left the supermarket chain in 2015 after a 3.1% fall in like-for-like Christmas sales and introducing a poorly received "Match and More" loyalty scheme. At the time Morrisons needed a turnaround strategy, unsurprisingly they didn't turn to Thompson to deliver it.

I'd already given you examples of his failure, including Test and Trace, along with his abject performance at the helm of RMG. ( see current share price, for example).

LSE, apologies for my misdemeanour.

Perhaps we could discuss "Two percent" Thompson's litany of failure in executive positions?.....

Apple
Morrisons
HSBC
Lastminute.com
Honda

His career reached a new low after the multi-billion pound "Test and Trace" debacle, following which, he was called to account by a HOC Select Committee.

He's now plumbing new depths at RMG, such that 98% of his own employees voted against his plans.

His track record is disastrous.